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PrionHsp104 in yeast and ClpB in bacteria are homologous, hexameric AAA+ proteins and Hsp100 chaperones,
which function in the stress response as ring-translocases that drive protein disaggregation and reactivation.
Both Hsp104 and ClpB contain a distinctive coiled-coil middle domain (MD) inserted in the ﬁrst AAA+
domain, which distinguishes them from other AAA+ proteins and Hsp100 family members. Here, we focus on
recent developments concerning the location and function of the MD in these hexameric molecular machines,
which remains an outstanding question. While the atomic structure of the hexameric assembly of Hsp104 and
ClpB remains uncertain, recent advances have illuminated that the MD is critical for the intrinsic disaggregase
activity of the hexamer and mediates key functional interactions with the Hsp70 chaperone system (Hsp70
and Hsp40) that empower protein disaggregation. This article is part of a Special Issue entitled: AAA ATPases:
structure and function.TPases: structure and function.
orter).
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Hsp104 and ClpB are homologous protein disaggregases, which
are classiﬁed in the Hsp100 family of proteins [1–9]. This family, in
turn, is a member of the AAA+ (ATPases Associated with various
cellular Activities) super-family [10–12]. Hsp104, which is found in
Saccharomyces cerevisiae, has two main functions. First, in collabo-
rationwith Hsp70 andHsp40, Hsp104 confers thermo- and chemical-
tolerance to yeast by resolubilizing stress-induced protein aggre-
gates and restoring proteins to native structure and function (Fig. 1a)
[13–18]. These aggregates are typically disordered or amorphous in
structure [19,20]. Additionally, Hsp104 can directly remodel amyloid
and this activity governs prion inheritance in yeast (Fig. 1b) [21–33].
Prions, which are proteins that adopt an infectious amyloid fold, are
structurally distinct from disordered aggregates in that they form
ordered assemblies with a characteristic ‘cross-β’ structure [20,34–
39]. Unlike their mammalian counterparts, yeast prions can confer
selective advantages, which are only made possible by the Hsp104-
catalyzed remodeling activities that facilitate stable prion inheri-
tance through successive generations [22,27,40–42]. Curiously,
Hsp104 is absent from metazoan lineages [43]. Thus, it has been
suggested that the ability of Hsp104 to remodel amyloid conformers
as well as toxic preamyloid oligomers might even be harnessed,
engineered and potentiated for therapeutics against numerousneurodegenerative amyloidoses [6,39,43–45]. Despite sharing over
50% identity with Hsp104, the bacterial protein ClpB does not possess
the same dual functionality as Hsp104. Like Hsp104, ClpB is able to
disaggregate amorphous substrates in response to environmental
stresses that induce widespread protein aggregation [46–50].
However, unlike Hsp104, ClpB appears to be ineffective at remodel-
ing amyloid conformers [21,51,52].
Signiﬁcant efforts have been made toward gaining a structural
understanding of Hsp104 and ClpB. Like many AAA+ proteins,
Hsp104 and ClpB are functional as ring-shaped hexamers [1,53,54],
which are thought to drive protein disaggregation by directly
translocating substrates through their central channel (Fig. 1a, b)
[55–60]. However, there is still no general consensus about the gross
domain organization within these hexameric molecular machines
[53,61–66]. Thus, how the hexamer couples conformational change to
generate the mechanical force necessary to drive protein disaggrega-
tion continues to remain uncertain. A point of particular contention is
the location and orientation of the unique coiled-coil insertion,
termed the Middle Domain (MD), within the hexameric assembly.
Despite a lack of detailed structural information, a number of studies
have recently revealed key mechanistic insights concerning how ClpB
and Hsp104 functionally interact with their respective Hsp70
chaperone system (Hsp70 and Hsp40), which is also activated during
the stress response [18,67–70]. Here, the elusive MD plays a critical
role that mediates the functional interaction between Hsp104/ClpB
and the Hsp70 chaperone system [67–69]. In this review, we will ﬁrst
outline the debate concerning the quaternary structural organization
of Hsp104 and ClpB and then explore the implications that the MD
mediates functional interactions with Hsp70.
Fig. 1. In vitro disaggregase activity of Hsp104 and ClpB. (a) Hsp104 remodels amorphous aggregates via collaboration with Hsp70 and Hsp40, while ClpB remodels these types of
aggregates via collaboration with DnaK, DnaJ, and GrpE (KJE). The product of disaggregation of amorphous aggregates is natively folded protein. Hsp104 or ClpB hexamer is shown in
gray with the front half cutaway to reveal the axial channel running down the length of the structure. Four pore loops with conserved tyrosine residues are shown in orange. These
pore loops are important for substrate binding and threading through the axial channel. (b) Only Hsp104 is able to remodel amyloid aggregates and in vitro this can proceed without
the aid of Hsp70 and Hsp40. Products of amyloid disaggregation are soluble natively folded protein and fragmented amyloids. However, for some amyloids (e.g. Sup35 prions)
remodeling can continue to generate disordered-type aggregates that Hsp104 cannot remodel and which lack the seeding activity of amyloid [23].
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the middle domain?
Each Hsp104 or ClpB monomer contains an N-terminal domain,
two AAA+ nucleotide-binding domains (NBD1 and NBD2), and a
predicted coiled-coil middle domain (MD) that is inserted toward the
C-terminal end of NBD1 (Fig. 2a) [1,2,71–73]. Additionally, Hsp104
contains a short C-terminal extension, absent from ClpB, which is
required for Hsp104 hexamerization [74]. The tertiary structure of the
individual domains was largely resolved in 2003 when a 3.0 Å crystal
structure of ClpB (TClpB) from the thermophilic eubacterium,
Thermus thermophilus, was solved by Tsai and colleagues (Fig. 2b)
[63]. These studies revealed that both NBDs adopt a canonical AAA+
fold [63]. The structure of NBD1 agreed with a previously solved
structure of this isolated domain [75]. The N-terminal domain, which
is the least conserved domain in the disaggregase family, was alsostructurally similar to the isolated Escherichia coli ClpB N-terminal
domain [76]. The MD was revealed as a broken anti-parallel coiled-
coil (Figs. 2b, 3b) [63]. For the purpose of this review, we have
provided a uniﬁed nomenclature to describe regions of the MD in
ClpB, TClpB, and Hsp104 (Fig. 3a, b). The MD is less well conserved
than NBD1 or NBD2, with Hsp104 and ClpB sharing only ~36%
identity. Unfortunately, full-length TClpB did not crystallize in its
functional hexameric structure, but rather in a trimeric spiral with
protomer–protomer interactions that might, at least in part, reﬂect
crystal contacts rather than native protomer interfaces. In a dynamic,
multi-domain molecular machine like Hsp104/ClpB, understanding
the relative domain positioning and protomer organization is
absolutely critical for understanding the mechanism of action.
The overall quaternary structure of Hsp104 and ClpB has been
investigated primarily by Cryo ElectronMicroscopy (Cryo-EM), which
has led to recent debate. It is generally agreed that Hsp104 and ClpB
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increased protein concentration [53,77–79], low salt [77,80], and the
presence of ADP or ATP [53,54,79–81]. Curiously, however, whileFig. 2. Predicted structures and hexameric models of Hsp104 and ClpB. (a) Domain organi
Nucleotide binding domain 1 (NBD1) shown in cyan, Middle domain (MD) in yellow, Nuc
extension (C) shown in green. Sequence numbering for ClpB is shown on top and for Hsp104
part (a). A 180° rotation about the vertical axis is shown on the right. (c) The Tsai model for th
Cryo-EM envelopes generated with TClpB is shown on left. (d) The Saibil model, which use
structure of hexameric, full-length ClpC is shown on the right. The adaptor protein MecA was
the N-terminus is shown on the bottom. One subunit is colored as described in part (a). Thnucleotide binding to NBD1 is critical for ClpB hexamerization [80],
this situation is reversed in Hsp104where nucleotide binding to NBD2
is key [53,78,79]. The underlying reason for this switch between NBDszation of one monomer of Hsp104 and ClpB. N-terminal domain (N) shown in purple,
leotide binding domain 2 (NBD2) in dark blue. Only Hsp104 has the short C-terminal
is shown on the bottom. (b) TClpB crystal structure. Domain coloring corresponds with
e hexameric quaternary structure of TClpB. The Tsai model, whichwas initially based on
d Hsp104 to generate Cryo-EM density, is shown in the middle. (e) The 6.93 Å crystal
omitted for clarity. A side view is shown on top and a view down the axial channel from
e other ﬁve subunits are in gray.
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contributes the majority of basal ATPase activity in Hsp104 [53,78,79],
whereas both NBDs contribute to basal ATPase activity in ClpB [80].
The ATPase activities of both NBDs are required for the full repertoire
of protein-remodeling activities and are modulated by allosteric
communicat ion within and between NBD1 and NBD2
[73,77,79,80,82–84]. Gross domain position and the protomer–
protomer interfacial packing of Hsp104 and ClpB hexamers still
remain uncertain. Of particular interest is the position of the coiled-
coil MD, which is necessary for disaggregase activity and is unique to
the Hsp100 chaperones that function primarily in disaggregation
[63,80,85]. In the TClpB crystal structure, this domain was jutting
obliquely from the axis of the other domains [63] (Fig. 2b). Thus, in the
original Cryo-EM reconstructions of TClpB in the presence of AMP-
PNP (a non-hydrolyzable ATP analog) the MD was assigned to
protrusions that appeared to emanate from one tier of the hexamer
[63] (Fig. 2c, Tsai model).
In subsequent studies, to determine any conformational reorgani-
zations that take place through the ATPase cycle, Cryo-EM envelopes
of TClpB in the ADP and apo state were reconstructed as well as the
envelope of the Double Walker B TClpB mutant (E271A:E668A) in the
presence of ATP [61]. This mutant binds but does not hydrolyze ATP at
both NBDs and has increased afﬁnity for substrate [61,86]. In all states,
a two-tiered hexamer with an axial channel running through theFig. 3. Middle domain nomenclature. (a) An alignment of the MD from E. coli ClpB, T. therm
purple, helix 3 is colored in light blue, and helix four is colored in yellow. Motif 1 (also ca
Arrowheads denote key residues discussed in the text. (b) Close up of the MD in the TClpB cr
for clarity. Arrows point to side chains (shown as sticks) of key residues discussed in the tecenter was clearly visible [61]. However, the N-terminal domain was
not visible as electron density [61]. In the AMP-PNP-bound state, the
TClpB envelope shows clear, well deﬁned protrusions on the outside
of the hexamer, which, when the individual domains of the TClpB
monomeric crystal structure were ﬁtted as rigid bodies into the
density, overlapped partially with predicted MD density [61,63]. It
was suggested that the exterior position of the MD might enable it to
act as a ‘crowbar’ to pry apart large aggregates [63]. Glover and
Lindquist had originally suggested that Hsp104 might possess a
‘crowbar activity’, but did not ascribe this activity to any particular
domain [16]. All the other nucleotide states of TClpB (ATP, ADP, and
apo) do not have such large protrusions of density that could correlate
with a MD projection. It was suggested that this might be due to the
inherent mobility of the coiled-coil MD [61]. Indeed, the main
difference between the different nucleotide states was the length of
these radially extending protrusions [61]. By contrast, the positions of
the AAA+ domains remained almost identical in the various
nucleotide states [61]. Consequently, these reconstructions do not
readily clarify the mechanochemical coupling events that drive
substrate translocation through the central channel.
This structural model of the hexamer was challenged by Cryo-EM
reconstructions of Hsp104 by Saibil and colleagues [64–66]. In these
studies, Cryo-EM reconstructions were generated of Hsp104 lacking
its N-terminal domain, ΔN-Hsp104, and an NBD2 sensor-1 Hsp104ophilus ClpB, and S. cerevisiae Hsp104. Helix 1 is colored in green, helix 2 is colored in
lled wing 2) is boxed in black while motif 2 (also called wing 1) is boxed in orange.
ystal structure. Each helix and motif is colored as indicated in part (a). NBD2 is omitted
xt.
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able to catalyze disaggregation of disordered aggregates in the
absence of Hsp70 and Hsp40, but is unable to remodel amyloid
[77,82]. Contrary to the TClpB reconstruction, Hsp104N728A had a
structured N-terminal domain and presented as a three-tiered
hexamer with no oblique MD protrusion [64–66]. The central cavity
of Hsp104N728A was also much larger than that observed with TClpB
and the modeled protomer–protomer packing was unlike that of
typical AAA+ structures [64–66]. It was hypothesized that the
enlarged cavity might serve as an adaptation necessary to remodel
large aggregated structures [64–66]. A TClpB-homology model of
Hsp104 was ﬁtted as a rigid body into the electron density with each
domain connected by a ﬂexible linker (Fig. 2d, Saibil model) [64–66].
The resulting ﬁts placed the MD intercalated within NBD1 and NBD2,
rather than projecting out into solution (Fig. 2d) [64–66]. This
physical proximity of the MD to both NBDs, which is also partially
supported by ﬂuorescence proximity studies of ClpB [87], might help
explain how the MD mediates communication pathways between
NBD1 and NBD2 [73].
The cryo-EM reconstructions of Hsp104N728A with ATPγS (a slowly
hydrolysable ATP analog), ATP and ADP were also generated [65,66].
Hsp104N728A displayed large nucleotide-dependent domain reorga-
nizations, with the ATPγS state having the most expanded central
cavity [65,66]. These domain movements displaced the substrate-
binding tyrosine loops in the central channel and triggered a
peristaltic motion that provides a clear structural basis for N- to C-
terminal substrate translocation [65,66]. Asymmetric reconstructions
of Hsp104N728A with ATPγS and ATP provided unprecedented insight
into disaggregase activity [65,66]. These reconstructions suggested a
sequential mechanism of ATP hydrolysis in NBD1 coupled to
clockwise handover of substrate in the NBD1 ring and a coordinated
handover between NBD1 and NBD2 [65,66]. Thus, the ﬁrst detailed
structural picture of the mechanochemistry that underpins protein
disaggregation emerged [4,65,66].
It remains unclear why the Cryo-EM reconstructions of TClpB and
Hsp104N728A would be so disparate. Could the differences simply
reﬂect a fundamental difference in hexamer architecture for the
prokaryotic and eukaryotic enzymes? Or could the different re-
constructions reﬂect the different protein preparations for the Cryo-
EM? For example, glutaraldehyde ﬁxationwas employed for the TClpB
studies [61,63], whereas ﬁxative was omitted for the Hsp104 studies
[64,65]. The story takes another twist when Tsai and colleagues
presented Cryo-EM reconstructions of a double Walker B Hsp104
mutant (E285A:E687A) in the presence of ATP and ΔN-Hsp104 in the
presence of ATPγS with and without glutaraldehyde ﬁxation [62].
Both sets of envelopes appeared very similar, indicating that ﬁxation
might not be an issue [62]. Intriguingly, and in contrast to their prior
TClpB reconstructions, there was a striking absence of additional mass
density on the outside of the ΔN-Hsp104 or Hsp104E285A:E687A
hexamer [62]. Indeed, the Cryo-EM envelopes of the different
Hsp104 variants constructed by the different groups are remarkably
similar, particularly for ΔN-Hsp104 plus ATPγS (especially when
either reconstruction is subjected to a 180° vertical rotation)
[62,64,65]. This similarity among Hsp104 envelopes might even
suggest that TClpB hexamers possess a subtly distinct architecture.
After all, Hsp104 is equipped to remodel amyloid, whereas ClpB is not
[21,51,52], so perhaps subtle structural differences might be antici-
pated. However, despite the absence of lateral projections emanating
from the Hsp104 hexamer, the authors placed the MD outside of the
hexamer walls in their atomic structure ﬁtting as with TClpB [62].
Thus, it is still unclear whether the MD of Hsp104 and ClpB is located
inside or outside of the hexamer. It should also be noted that no
reconstructions have been presented with full-length wild-type
Hsp104.
In an effort to visualize the MD during Cryo-EM, an Hsp104
chimera was generated with T4 lysozyme inserted into the MD [62].Because the lysozyme was visible as density on the outside of the
hexamer, it was suggested that the MD must also be located on the
exterior [62]. However, density corresponding to the MD itself on the
outside of the hexamer could still not be readily visualized even with
this artiﬁcial construct [62]. It is extremely probable that this large-
scale (19 kDa) insertion disrupts the native quaternary structure of
Hsp104, especially since the insertion was located in a helical region
of the MD (between residues N467 and E468 of helix 2 (Fig. 3a, b))
and not in a predicted loop region. Indeed, although this chimera
possesses some disaggregation activity against non-native substrates
in vitro, it should be noted that its ATPase activity was elevated,
hexamerization was perturbed, disaggregase activity was dysregu-
lated and the functionality was not assessed in vivo [62,69]. Thus, it is
not clear whether the two models can really be distinguished with
this insertion variant despite its partial functionality in some settings.
Rather, the ability of the Hsp104 to accommodate such a large
insertion and retain some activity indicates an extraordinary plasticity
of the hexamer.
Additionally, the structure of Hsp104 and ClpB has been
investigated using biochemical techniques other than Cryo-EM.
Engineered disulﬁde cross-links in ClpB that covalently link NBD1 to
motif 2 of the MD (Fig. 3a, b) have shown that these two domains are
closely associated and that movement of the MD is crucial for
disaggregation [63,67]. Unfortunately, these cross-links do not
differentiate between the two models because the MD is closely
associated with NBD1 in both proposed structures [61–66]. Impor-
tantly, the MD is inaccessible to three monoclonal antibodies that
recognize native MD epitopes [73] in Hsp104 hexamers, but is
exposed in Hsp104 monomers [65]. These data suggest that the MD
becomes shielded upon hexamerization but remains accessible and
solvated when Hsp104 is monomeric [64–66]. This observation might
explain why monomeric TClpB crystallized with the MD jutting away
from the axis of the NBDs. However, in contrast to these results, Lee et
al. inserted a short StrepII tag (WSHPQFEK) into the MD (between
residues N467 and E468 of helix 2 (Fig. 3a, b)) of Hsp104 and
employed dot blots to determine whether the tag was exposed in
monomeric and hexameric StrepII-tagged Hsp104 [62]. These studies
suggested that the StrepII tag was accessible in monomeric and
hexameric forms of Hsp104 [62]. Unfortunately, however, it is
uncertain whether this epitope tag is truly innocuous or partially
disruptive. Moreover, these data are difﬁcult to assess because it is not
clear whethermonomeric and hexameric Hsp104were spotted on the
same dot blot [62]. Thus, one cannot be certain from the presented
data whether the signal intensities for monomeric and hexameric
conformers are directly comparable [62].
Another major difference between the hexameric models is the
positioning of the putative arginine ﬁngers [61–66]. Typically, an
arginine ﬁnger is an arginine residue that coordinates the γ-
phosphate of a bound nucleotide and is a recurring characteristic of
AAA+ family members [10]. In many AAA+ proteins the arginine
residue is located distal to the nucleotide-binding site and is provided
by the adjacent subunit of the oligomer [10,88,89]. Arginine ﬁngers
contribute to ATP hydrolysis through stabilization of the transition
state [10]. When the MD is positioned on the exterior of the hexamer
the arginine-ﬁnger residues are positioned in a canonical position
reaching into the nucleotide-binding site of an adjacent protomer
[10,61–63]. By contrast, when the MD is intercalated between NBDs
the arginine ﬁngers are in a non-canonical position [64,65]. However,
it should be noted that the arginine ﬁnger is not conserved in all
members of the AAA+ family, and it is not clear if the position of this
motif in the oligomeric structure is stringently conserved among all
the different clades of the family. For example, in some crystal
structures, the predicted arginine ﬁnger of HslU, an Hsp100 and AAA+
family member with only one NBD, is approximately 8 Å from the
nucleotide-binding site [90]. In this regard, it is interesting to note that
themissensemutation, R444M, in thedistal loop regionbetweenhelices
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impairs thermotolerance in a dominant-negative manner and disrupts
amyloid remodeling functionality [64]. This deﬁciency may suggest a
close contact between thedistal loop of theMDand theNBD2 [64]. Thus,
it is possible that other conserved arginines might fulﬁll the role of the
arginine ﬁnger in Hsp104.
Finally, a crystal structure of another Hsp100 family member from
Bacillus subtilis, ClpC, was recently solved and has weighed in on the
debate [91] (Fig. 2e). Like ClpB and Hsp104, ClpC is an AAA+
disaggregase involved in modulation of stress response [92] and
protein quality control [93]. Typically, ClpC passes disaggregated
substrates to the chambered protease, ClpP, for degradation [91–94].
While ClpC is natively a hexamer, it requires an adaptor protein,
MecA, to oligomerize and form an active enzyme [95,96]. By
employing a variant with four loop deletions and two ATPase-
obliterating mutations, a 6.93 Å crystal structure of hexameric ClpC in
complex with the adaptor protein MecA was obtained [91].
Interestingly, the packing within the NBD1 ring corresponded well
with that proposed for TClpB [61,63,91] (Fig. 4). Additionally, the MD
of ClpC, which is approximately half the length of the MD of ClpB [96],
was also jutting out and away from the NBDs and was distinctly
located on the outside of the hexamer [91]. These data provide
independent support for the TClpB hexameric model. However, the
coiled-coil domain of ClpC is considerably shorter than that of Hsp104
or ClpB and must interact with MecA so that ClpC can hexamerize
[91]. Thus, the MD of ClpC plays a very different role to the MD of ClpB
or Hsp104 where it is dispensable for hexamerization [69,80].
In closing this section, we suggest that further biochemical
characterization and alternative techniques are urgently needed to
discern which hexameric model is correct or whether a revised model
is required for Hsp104 and ClpB. It is probable that both models are
partially correct because Hsp104 and ClpB are large, oligomeric
machines that possess signiﬁcant domain plasticity [62,63,69].
Potentially, the MD might be able to occupy both structural
conformations depending on the stage of the disaggregase cycle.
Two factors are likely to have greatly increased the difﬁculty in
obtaining high-resolution structural information on the Hsp104 or
ClpB hexamer. First, the hexamer is highly dynamic and monomers
are exchanged on the minute timescale [97,98]. Second, individual
subunits or domains likely adopt different conformations within the
hexamer [65,66]. Future studies employing a full gamut of comple-
mentary techniques will be essential to reﬁne our understanding of
the hexameric structure of Hsp104 and ClpB.
3. The function of the MD
Despite the ambiguity in MD location, several studies have probed
MD function. For instance, in ClpB, deletion of the MD causes a loss ofFig. 4.Overlay of ClpB and ClpCmonomers. ClpB and ClpCmonomers were aligned by their A
in Fig. 2 with the N domain in purple, NBD1 in cyan, MD in yellow, and NBD2 in dark blue. All
N-terminal domain (marked with an arrow) and the different angle of the ClpC MD (markthermotolerance function [80]. Furthermore, partial truncations of the
ClpBMD cause decreased ATPase activity, hexamerization defects, and
impaired disaggregation [99]. Even point mutations in the MD have
been implicated in altered ATPase activity, loss of thermotolerance
activity, and/or destabilization of the hexamer [64,67,85,100]. The
dynamic mobility of the MD also appears critical for Hsp104/ClpB
function, as crosslinks that hinder MD ﬂexibility reduce or ablate
disaggregation activity of ClpB [63,67]. Additionally, the MD appears
to be involved in facilitating NBD1 and NBD2 communication [73]:
when motif 2 is covalently attached to NBD1, ATPase activity in NBD2
increases by ~30-fold [87]. Clearly, the structural integrity and relative
mobility of the MD must be maintained for full disaggregase
functionality.
At ﬁrst glance, the MD appears to differentiate Hsp100 proteins
that possess disaggregase activity from other Hsp100s. The disag-
gregases: ClpB and ClpC [98,101,102] in bacteria, Hsp104 and Hsp78
[103–106] in yeast, as well as Hsp101 [107–110] in plants, all contain
a coiled-coil insertion toward the C-terminal end of NBD1. ClpE is
another bacterial homologue that contains a coiled-coil insertion
[111,112]. Genetic studies have implicated ClpE as part of the cellular
disaggregation machinery, but this has yet to be demonstrated with
pure protein biochemistry [113]. While there are several examples of
Hsp100 proteins that do not contain a MD and also do not possess
disaggregase activity [114], the correlation between MD and disag-
gregase function is not quite so straightforward. For instance, ClpV,
another bacterial Hsp100 protein, also contains a predicted MD
insertion between its two AAA+ domains but does not possess any
disaggregation activity against substrates in vivo [115]. Additionally,
ClpA, another Hsp100 and AAA+ protein with two NBDs per
monomer found in E. coli (but not in yeast), displays disaggregase
activity against disordered aggregates but does not harbor a coiled-
coil MD [82,116]. Indeed, in collaboration with its adaptor protein,
ClpS, ClpA disaggregates substrates and delivers them to ClpP for
degradation [116]. ClpA disaggregates substrates without any need for
the Hsp70 chaperone system [114,116], indicating that Hsp70 is not
absolutely required for disaggregation per se. Importantly, however,
the Hsp70 chaperone system inhibits protein disaggregation by ClpA
[116]. In this way, DnaK prevents degradation of aggregated sub-
strates by ClpAP in E. coli and permits their disaggregation and
reactivation by ClpB [116]. Since the MD is a major distinguishing
feature of ClpB compared to ClpA, these studies provided the ﬁrst hint
that the MD might contribute to collaboration with Hsp70.
Hsp104 and ClpB require collaboration with Hsp70 and Hsp40
chaperones for successful disaggregation of amorphous aggregates,
both in vitro and in vivo [13,16,47,49,117,118]. Hsp70 and Hsp40 can
also ameliorate the amyloid-remodeling activity of Hsp104
[24,28,44,51,119]. In yeast, members of the Hsp70 chaperone family
(e.g. Ssa1, Ssb1) and Hsp40 family (e.g. Ydj1 and Sis1) have beenAA+ domains using Pymol. The resulting RMSDwas 3.4. Domains for ClpB are colored as
domains in ClpC are colored in orange. Note the drastically different position of the ClpB
ed with an asterisk).
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bacteria, the homologous DnaK and DnaJ (along with the nucleotide
exchange factor GrpE) (KJE) collaborate with ClpB [46,48,49]. The
exact mechanisms by which Hsp70 and Hsp40 collaborate with
Hsp104 are largely unresolved. However, two key functions are
commonly ascribed. First, Hsp70 is proposed to act upstream of
Hsp104 or ClpB by interacting with the aggregate and shuttling
substrate into the axial channel of Hsp104 or ClpB (Fig. 1a)
[16,58,67,98,120–122]. Second, Hsp70 is proposed to act downstream
of Hsp104 and promotes refolding of unfolded polypeptides once they
emerge from the axial channel [16,49,82,86].
The Hsp70 chaperone system, however, may fulﬁll a third role by
modulating the ATPase activity of Hsp104/ClpB in a manner that
promotes the successful disaggregation of disordered aggregates
[2,82,114]. Indeed, mixing of ClpB with KJE results in a synergistic
increase in global ATPase activity [114]. Moreover, the requirement
for Hsp70 to disaggregate certain disordered aggregates can be
bypassed altogether by addition of speciﬁc mixtures of ATP:ATPγS
(3:1 for Hsp104 and 1:1 for ClpB), or by introducing speciﬁc Walker A
(e.g. K620T in Hsp104), Walker B (e.g. E279Q or E678Q in ClpB) or
sensor-1 (e.g. N728A in Hsp104) mutations into either NBD1 or NBD2
[82–84,114,123]. Thus, part of the function of Hsp70 might be to ‘set’
Hsp104 ATPase activity in a mode in which predominantly one NBD is
rapidly hydrolyzing ATP. Thismode of ATPase activity can be sufﬁcient
to promote the disaggregation of disordered aggregates
[65,82,114,123]. However, it precludes amyloid remodeling by
Hsp104 [82]. Further studies are needed to deﬁne the precise
mechanisms by which Hsp70 promotes protein disaggregation by
Hsp104. Moreover, it has long remained unclear how the functional
interaction between Hsp104 and Hsp70 is mediated and what
domains of either protein are required. Recent studies, however,
ascribe a critical role for the MD in promoting communication with
the Hsp70 system.
4. The role of the MD in Hsp70 chaperone collaboration
Interestingly, it has long been clear that Hsp104 is unable to
collaborate with the bacterial Hsp70 chaperone system [16]. Likewise,
ClpB is unable to collaborate with the yeast Hsp70 chaperone system
[106]. This situation is often referred to as the ‘species-speciﬁc’
interaction between Hsp104 and Hsp70 [2,68,69]. However, the term
‘species speciﬁc’ should not be taken too literally. Hsp104 is able to
collaborate effectively with the mammalian Hsp70 chaperone system
[44,84,124] and multiple eukaryotic Hsp104 homologues can com-
plement the thermotolerance function of Hsp104 in yeast (but
interestingly not always the prion propagation function of Hsp104)
[125–128], whereas ClpB cannot [51,70]. Rather, it seems that
eukaryotic Hsp100s are unable to collaborate with prokaryotic
Hsp70, and likewise prokaryotic Hsp100s cannot collaborate with
eukaryotic Hsp70. Within prokaryotes, TClpB cannot collaborate with
DnaK from E. coli [129]. Moreover, Ssa1 and DnaJ can collaborate with
Hsp104, whereas DnaK and Ydj1 cannot [16]. Thus, the key speciﬁcity
determinant appears to be the Hsp70 chaperone rather than the
Hsp40.
Yet, deﬁning whether or how Hsp70 or Hsp40 might interact
directly with Hsp104 has proven remarkably difﬁcult. Initial evidence
suggested that Hsp104 coimmunoprecipitates with Ydj1, but not Sis1,
from yeast extracts [16]. Using pure proteins, a weak physical
association has been observed between hexameric ClpB and DnaK
[129]. In another study, DnaJ was found not to interact with ClpB,
whereas the substrate-binding domain of DnaK was required for an
interactionwith ClpB [130]. This interactionwas disrupted by deletion
of the N-terminal domain of ClpB and was partially disrupted by
deletion of portions of the coiled-coil MD of ClpB [130]. These data
indicated that DnaK might interact with the N-terminal domain and
MD of ClpB [130]. However, it is not clear whether these interactionsreﬂect speciﬁc functional interactions between ClpB and DnaK that
are required for protein disaggregation, or whether they reﬂect the
chaperone activity of DnaK, which would recognize and bind
transiently unfolded portions of ClpB.
The ﬁrst functional evidence for the interaction between the MD
and the Hsp70 chaperone system was uncovered by characterization
of speciﬁc helix 3 MD mutants (e.g. Y503D; Fig. 3a,b) [67] (Table 1).
ClpBY503D was unable to collaborate with KJE in protein disaggrega-
tion [67]. However, ClpBY503D formed hexamers, had elevated ATPase
activity and translocated unfolded polypeptides [67]. The speciﬁc
defect in ClpBY503D was pinpointed to an inability of KJE to shuttle
aggregated substrates to the NBD1 channel loop [67]. Thus, it was
concluded that theMD functions to couple the interaction with Hsp70
to translocation of aggregated substrates [67]. Yet, a direct interaction
between helix 3 of the MD and DnaK was not observed [67]. Rather,
helix 3 of the MD displays conformational ﬂexibility that is necessary
to regulate a direct interaction between helix 3 of the MD and NBD1
[67]. Mutations in helix 3 (e.g. Y503D) cause this interaction to
become dysregulated and consequently ATPase activity becomes
elevated to such an extent that substrate handover from KJE to the
ClpB channel can no longer be co-ordinated [67]. Thus, these studies
revealed that helix 3 of the MD indirectly controls the functional
interaction with Hsp70 through a direct interaction with NBD1.
The established connection between the MD and Hsp70 [67]
stimulated efforts to utilize chimeras of Hsp104 and ClpB to determine
which domain(s) of Hsp104 would enable ClpB to function in yeast
(Fig. 5) [51,68,69]. Thus, each domain (N, NBD1, MD and NBD2) was
treated as a module and chimeras were constructed that had various
combinations of modules from either ClpB or Hsp104 [51,68,69]
(Fig. 5). For example, the chimera 444B contains the N-terminal
domain, NBD1 and MD of Hsp104 plus NBD2 of ClpB. In an initial
study, 444B and _44B (444B with the N-terminal domain deleted)
could function in thermotolerance and prion propagation, indicating
that either the N-terminal domain, NBD1 or the MD of ClpB might
preclude activity in yeast [51]. Subsequent studies revealed that the
MD plays a critical role [68]. Thus, BB4B was able to partially
complement Hsp104 in thermotolerance (Fig. 5) [68], but was
inactive in propagation of the yeast prion [PSI+] [51]. Moreover,
BB4B and a similar construct could now collaborate with eukaryotic
Hsp70 to promote the disaggregation of disordered aggregates in vitro
(Fig. 5) [68,69]. Thus, the MD of Hsp104 enables ClpB to functionally
interact with eukaryotic Hsp70.
Curiously, however, the converse domain transplant was not
nearly as successful (Fig. 5). Thus, 44B4 could not collaborate with KJE
in vitro or in E. coli (Fig. 5) [68]. Another study found that 44B4 had
ATPase activity, formed hexamers and could weakly collaborate with
KJE in disaggregation in vitro [69]. Thus, simply transplanting the MD
of ClpB into Hsp104 does not enable Hsp104 to collaborate with DnaK
in the same way that ClpB can [68]. Rather, additional sequences
appeared to be required. The addition of the NBD1 of ClpB helped
restore activity to wild-type ClpB levels [68]. Thus, 4BB4 was active in
vitro with KJE and in E. coli [68]. Curiously, 44BB has not been studied.
Collectively, these data assert that the MD of Hsp104 is extremely
important for a functional interaction with eukaryotic Hsp70 in the
disaggregation of disordered aggregates [68,69]. However, the
situation with ClpB is more complex as the MD of ClpB does not
enable or only minimally enables Hsp104 to interact functionally with
KJE [68,69]. Surprisingly, no mechanistic explanation for this disparity
has been advanced [68,69]. Moreover, although these studies [68,69]
strengthen the functional interaction between the MD and Hsp70,
there is still no compelling evidence for a direct interaction between
theMD and Hsp70 that is required for protein disaggregation. A hint is
provided by a bacterial two-hybrid system in which the MD of ClpB
appears to confer (in some constructs) the ability to interact
physically with DnaK, although it remains possible that this
interaction might still be indirect [68]. Even in this experiment,
Table 1
Selected MDmissense mutants. Activity relative to wild-type (WT) Hsp104 is shown in green symbols and activity relative to WT ClpB is shown in blue symbols. ++ indicates that
mutant displayed greater activity than WT, + indicates that the mutant displayed comparable activity to WT, − indicates that mutant displayed less activity than WT, while Ø
indicates that no activity was observed for the mutant tested. Blank cells indicate that the mutant was not tested for this activity. Please note that this is not an exhaustive table of
tested MD mutations. For a more exhaustive listing of characterized MD missense mutants, see Barends and colleagues review [4].
Mutation Reference # Forms
hexamers?
ATPase
activity?
Able to
translocate?
Disaggregate amorphous
aggregates in vitro?
Disaggregate amyloid
aggregates in vitro?
Functional in
thermotolerance?
Functional in
[PSI+] propagation?
ClpBY503D 67 Yes n/a n/a
Hsp104R419M 64 Yes
Hsp104R444M 64 Yes
Hsp104R495M 64 Yes
Hsp104L462R 134
Hsp104A503V 85, 134–136
36 M.E. DeSantis, J. Shorter / Biochimica et Biophysica Acta 1823 (2012) 29–3944B4 displayed a signal that was only slightly higher than background,
indicating that the MD of ClpB is insufﬁcient to confer an interaction
with DnaK [68]. Here too, there is still the concern that apparentFig. 5. Summary of ClpB and Hsp104 chimera activity. Cartoon representation of the domain
and blue cylinders represent ClpB domains. Activity relative to wild-type (WT) Hsp104 is sh
indicates that the chimera displayed greater activity thanWT, + indicates that the chimera d
WT, while Ø indicates that no activity was observed for the chimera tested. Blank cells indica
ATPase activity, increase in ATPase activity upon binding α-casein, the ability to bind α-case
association with DnaK as measured by a bacterial 2-hybrid system were tested. Additional
protein (GFP), β-galactosidase (β-Gal), and malate dehydrogenase (MDH) were tested.speciﬁcity in the bacterial two-hybrid system might stem from the
chaperone activity of DnaK rather than from a direct, functional
interaction that is required for disaggregase activity. Further studies inchimeras utilized in references [51,68,69]. Green cylinders represent Hsp104 domains
own in green symbols and activity relative to WT ClpB is shown in blue symbols. ++
isplayed comparable activity toWT, - indicates that chimera displayed less activity than
te that chimera was not tested for this activity. [PSI+] propagation, [RNQ+] propagation,
in, conferred thermotolerance in E. coli, conferred thermotolerance in S. cerevisiae, and
ly, DnaK, DnaJ, and GrpE and Hsp70/40 mediated disaggregation of Green ﬂuorescent
37M.E. DeSantis, J. Shorter / Biochimica et Biophysica Acta 1823 (2012) 29–39this system, which pinpoint the exact residues in ClpB and DnaK that
are necessary for interaction might be informative.
To determine the precise region within the MD that is required for
collaboration with DnaK or Hsp70 another series of ClpB chimeras
were generated [68]. Thus, the MD of these chimeras was comprised
of various combinations of helices 1, 2, 3 or 4 from Hsp104 or ClpB
(Fig. 5). These studies indicate that helices 2 and 3 of the ClpB MD are
important for a functional interaction with DnaK, whereas helices 1, 2
and 3 of the Hsp104 MD are important for an interaction with
eukaryotic Hsp70 [68]. However, a singlemissensemutation in helix 2
that disrupted the functional interaction with DnaK could not be
identiﬁed [68]. By contrast, the Y503D mutation in helix 3 of the ClpB
MD ablates any collaborationwith DnaK, even though this region does
not interact with DnaK directly [67]. This latter ﬁnding raises the
possibility that all the chimeric proteins that fail to interact with DnaK
in protein disaggregation [68,69] might only fail to do so because, in
the chimera, the communication between NBD1 and helix 3 of theMD
(that is necessary for collaboration with KJE) is disrupted in a manner
akin to ClpBY503D. That is, perhaps due to unanticipated, long-range
structural effects, the chimera is unable to support the appropriate
communication between NDB1 and helix 3 of the MD, which is
paramount for collaboration with KJE. Thus, chimera dysfunction
might not reﬂect loss of a direct interaction between DnaK and theMD
per se. Rather, chimeras might be unable to collaborate with KJE
because of an indirect, long-range structural effect that disrupts
communication between NBD1 and helix 3 of the MD. Further studies
are needed to resolve these issues and to pinpoint the exact sites
where DnaK and ClpB might interact directly.
5. Hsp70-Independent functions of the MD
Interestingly, amyloid remodeling by Hsp104 does not absolutely
require Hsp70 and Hsp40 in vitro [21,23,24,44,131–133], which
suggests that the disaggregation of ordered aggregates may proceed
by a different reaction mechanism than amorphous aggregate
remodeling. This independence from Hsp70 also provides an
opportunity to assess the function of the MD toward the intrinsic
disaggregase activity of Hsp104. The MD plays an important role in
this intrinsic amyloid-remodeling activity of Hsp104, as individual
missense mutations in conserved MD arginines (R419, R444 or R495)
ablate the ability of Hsp104 to remodel infectious amyloid forms of
Sup35 [64] (Table 1). Thus, the MD plays a critical role in disaggregase
activity even in the absence of Hsp70 [64].
Consistent with these in vitro observations, several mutations in
the MD of Hsp104 impair prion propagation in vivo [134–136].
Intriguingly, some of these mutations impair propagation of the yeast
prion [PSI+], which is comprised of infectious amyloid forms of Sup35,
but have no effect on thermotolerance. MD mutants that fall in this
class include L462R and A503V (Fig. 3a,b) [85,134–136] (Table 1). The
mechanistic explanation for the ability of these speciﬁc MD mutants
to promote the disaggregation of stress-induced disordered aggre-
gates while simultaneously being unable to promote the amyloid-
remodeling events required for prion propagation is unknown.
Nonetheless, these data hint that Hsp104 might exploit subtly
different mechanisms to remodel amyloid versus disordered aggre-
gates, and that the MD plays a key role in these different mechanisms.
6. Concluding remarks
In closing, we note that despite several important advances
described above, many aspects of the role of the MD in Hsp104 and
ClpB activity remain elusive. First, the location of the MD within the
hexameric assembly remains a point of debate [61–66,91]. Second,
although the MD appears to control the functional collaboration with
the Hsp70 chaperone system and even confers some ability to enable
chimeric disaggregases to traverse the S. cerevisiae – E. coli speciesbarrier (in one direction at least), precisely how this is achieved and
whether the MD interacts with Hsp70 directly is still unclear [51,67–
69]. Finally, single missense mutations in the MD of Hsp104 can have
dominant gain-of-function mutations with highly unexpected bio-
logical consequences [85]. Perhaps one of the most surprising
examples is provided by A503V [85,134,135]. This mutant confers a
growth defect at 37 °Cwhen expressed at high levels, but surprisingly,
is more active than wild-type Hsp104 in thermotolerance [85].
Furthermore, Hsp104A503V cannot support propagation of the yeast
prion [PSI+] [85,134]. Yet, remarkably, Hsp104A503V is considerably
more effective than wild-type Hsp104 in antagonizing polyglutamine
aggregation and toxicity in yeast models of Huntington's disease
[135]. This surprising therapeutic gain-of-function suggests that MD
mutations should be intensively explored in our efforts to identify
novel Hsp104 variants with enhanced disaggregase activity against
speciﬁc proteins that misfold, aggregate and confer toxicity in several
increasingly prevalent and presently untreatable neurodegenerative
disorders [6,39,43].
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